Martin Price

Martin Price
Martin Price is Vice President of Health Economics, Market Access and Reimbursement for Europe, Middle East and Africa at the Janssen Pharmaceutical Companies of Johnson & Johnson, a role he has held for the past five years. In this capacity, Martin leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Janssen’s new products and indications. Prior to this, Martin worked in Janssen’s UK affiliate, latterly as External Affairs Director, where he was responsible for Market Access, Communications and Government Affairs. Martin joined Janssen in 2001 from GlaxoSmithKline, where he began his …
Martin Price is Vice President of Health Economics, Market Access and Reimbursement for Europe, Middle East and Africa at the Janssen Pharmaceutical Companies of Johnson & Johnson, a role he has held for the past five years.

In this capacity, Martin leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Janssen’s new products and indications.

Prior to this, Martin worked in Janssen’s UK affiliate, latterly as External Affairs Director, where he was responsible for Market Access, Communications and Government Affairs.

Martin joined Janssen in 2001 from GlaxoSmithKline, where he began his career as Senior Health Outcomes Manager.

Martin has a broad pharmaceutical experience spanning more than 30 years and holds a PhD in Pharmacy from the University of Cardiff.
See more

Articles: Martin Price

Proposed Solutions to the Access Challenges Facing Cancer Medicines in Europe

Europe / Janssen’s EMEA market access head Martin Price outlines the regulatory changes that need to be made for patients across Europe to better access cutting-edge cancer medicines.   Recent advances in medical science are the driving force behind the research and successful development of innovative cancer treatments in Europe. By targeting the specific characteristics of the…

See more